MLH1 and gastric cancer: Patients with gastric cancer with MLH1 hypermethylation (≥ 0.23) showed better prognosis than those with MLH1 hypomethylation (< 0.23) (5-year OS: 84.5% vs 60.5%, P = 0.0019) (Fig 3C).